| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|
| Cash and cash equivalents | 120 | 863 | 293 | |
| Accounts receivable, net of allowance of 6,143 and 6,294 as of september 30, 2025 and december 31, 2024, respectively | 6,705 | 11,152 | 14,968 | |
| Inventory | 2,563 | 4,410 | 6,197 | |
| Prepaid expenses and other current assets | 1,208 | 838 | 622 | |
| Total current assets | 10,596 | 17,263 | 22,080 | |
| Property and equipment | 94,467 | 94,467 | 94,467 | |
| Less accumulated depreciation and amortization | 37,243 | 35,795 | 34,333 | |
| Property and equipment, net | 57,224 | 58,672 | 60,134 | |
| Investments equity securities | 2,890 | - | - | |
| Goodwill | 7,347 | 7,347 | 7,347 | |
| Intangible assets, net | 8,132 | 8,508 | 8,880 | |
| Right-of-use assets - operating leases | 10,743 | 10,769 | 10,798 | |
| Restricted cash | 10,135 | 10,073 | 10,011 | |
| Inventory, net of current portion | 6,952 | 7,409 | 9,372 | |
| Other noncurrent assets | 220 | 242 | 254 | |
| Total assets | 114,239 | 120,283 | 128,876 | |
| Acquisition-related contingent consideration | - | 0 | 0 | |
| Accounts payable | 24,587 | 24,400 | 23,313 | |
| Accrued expenses and other current liabilities | 29,421 | 33,369 | 25,248 | |
| Common stock to be issued | - | 1,010 | - | |
| Short-term debt-Nonrelated Party | - | 2,648 | 2,492 | |
| Short-term debt-Related Party | 4,284 | 4,297 | 4,161 | |
| Short-term licensing obligation | 1,438 | - | - | |
| Deferred revenue | 5,584 | 3,503 | 3,476 | |
| Total current liabilities | 65,314 | 69,227 | 58,690 | |
| Deferred revenue, net of current portion | 2,764 | 2,869 | 2,804 | |
| Acquisition-related contingent consideration, net of current portion | 1,413 | 1,413 | 1,413 | |
| Long-term debt - related parties-Related Party | - | 36,492 | 36,492 | |
| Long-term lease liabilities - operating | 26,806 | 26,717 | 26,631 | |
| Warrant liabilities | 3,524 | 8,780 | 8,067 | |
| Long-term licensing obligation | 34,234 | - | - | |
| Deferred income tax liabilities | 9 | 9 | 9 | |
| Other liabilities | 269 | 273 | 276 | |
| Total liabilities | 134,333 | 145,780 | 134,382 | |
| Accumulated other comprehensive loss | - | -3 | 0 | |
| Common stock, 0.0001 par value, 730,000,000 shares authorized, 28,216,485 and 22,546,671 issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 3 | 2 | 2 | |
| Additional paid-in capital | 947,004 | 918,529 | 913,993 | |
| Accumulated deficit | -967,101 | -944,025 | -919,501 | |
| Total stockholders (deficit) equity | -20,094 | -25,497 | -5,506 | |
| Total liabilities and stockholders (deficit) equity | 114,239 | 120,283 | 128,876 | |
Celularity Inc (CELUW)
Celularity Inc (CELUW)